Advertisement

Topics

RTI Surgical, Inc. (NASDAQ:RTIX) Upgraded to Buy by Zacks Investment Research

21:52 EDT 2 Jul 2017 | Topix

The firm presently has a $6.25 price objective on the medical equipment provider's stock. Zacks Investment Research 's price objective would indicate a potential upside of 6.84% from the company's previous close.

Original Article: RTI Surgical, Inc. (NASDAQ:RTIX) Upgraded to Buy by Zacks Investment Research

NEXT ARTICLE

More From BioPortfolio on "RTI Surgical, Inc. (NASDAQ:RTIX) Upgraded to Buy by Zacks Investment Research"

Advertisement
Quick Search
Advertisement
Advertisement